Page last updated: 2024-12-08
beta-methyllanthionine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 191096 |
MeSH ID | M0046396 |
Synonyms (18)
Synonym |
---|
42849-28-5 |
beta-methyllanthionine |
butanoic acid, 2-amino-3-((2-amino-2-carboxyethyl)thio)-, (2s-(2r*,3r*(s*)))- |
mz6ahu9tao , |
unii-mz6ahu9tao |
beta-methyl-lanthionine |
j174.792d , |
(2s,3s)-2-amino-3-((2r)-2-amino-2-carboxyethyl)sulfanylbutanoic acid |
(2s,3s)-2-amino-3-((2r)-2-amino-3-hydroxy-3-oxopropyl)sulfanylbutanoic acid |
(2s,3s,6r)-2,6-diamino-3-methyl-4-thiaheptanedioic acid |
3-methyllanthionine, (2s,3s,6r)- |
butanoic acid, 2-amino-3-(((2r)-2-amino-2-carboxyethyl)thio)-, (2s,3s)- |
(2s,3s,2'r)-.beta.-methyllanthionine |
(2s,3s,6r)-3-methyllanthionine |
(2s,3s)-2-amino-3-(((2r)-2-amino-2-carboxyethyl)thio)butyric acid |
DTXSID70195533 |
Q27284308 |
(2s,3s)-2-amino-3-[(2r)-2-amino-2-carboxyethyl]sulfanylbutanoic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.00
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.00) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (6.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (93.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |